Slides
Page 1
Q4 and full year 2025 earnings presentation Making Life Better
Page 2
2 Forward-looking statements This presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to expectations of Ingersoll Rand Inc. (the “Company” or “Ingersoll Rand”) regarding the performance of its business, its financial results, its liquidity and capital resources and other non-historical statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “on track to” “will continue,” “will likely result,” “guidance” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. All statements other than historical facts are forward-looking statements. These forward-looking statements are based on Ingersoll Rand’s current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from these current expectations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) adverse impact on our operations and financial performance due to geopolitical tensions, natural disaster, catastrophe, global pandemics, cyber events, or other events outside of our control; (2) unexpected costs, charges or expenses resulting from completed and proposed business combinations; (3) uncertainty of the expected financial performance of the Company; (4) failure to realize the anticipated benefits of completed and proposed business combinations; (5) the ability of the Company to implement its business strategy; (6) difficulties and delays in achieving revenue and cost synergies; (7) inability of the Company to retain and hire key personnel; (8) evolving legal, regulatory and tax regimes; (9) changes in general economic and/or industry specific conditions; (10) actions by third parties, including government agencies; and (11) other risk factors detailed in Ingersoll Rand’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in its periodic filings with the SEC, which are available on the SEC’s website at http://www.sec.gov. The foregoing list of important factors is not exclusive. Any forward-looking statements speak only as of the date of this presentation. Ingersoll Rand undertakes no obligation to update any forward-looking statements, whether as a result of new information or developments, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Non-GAAP Financial Measures Included in this presentation are certain non-GAAP financial measures designed to supplement, and not substitute, the financial information provided in accordance with generally accepted accounting principles (“GAAP”) in the United States of America because management believes such measures are useful to investors. The reconciliation of those measures to the most comparable GAAP measures for historical periods is set forth in the appendix to this presentation. Reconciliations of non-GAAP measures related to full-year 2026 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.
Page 3
3 Premier growth compounder with iconic brands and market leading positions We are a 01 02 03 3 Despite the complex global environment, including pressure from tariffs, we delivered positive organic orders growth, low single-digit adjusted EPS growth, and healthy free cash flow. Our Economic Growth Engine delivers durable financial results Staying nimble through our competitive differentiator, IRX We are committed to using our Economic Growth Engine to outperform in the markets in which we serve, while focusing on what we can control. Robust M&A funnel enabling future inorganic growth We remain disciplined in our approach to M&A. Our acquisition pipeline is strong and is primarily focused on targeted bolt-on opportunities.
Page 4
4 Inorganic growth flywheel remains strong Acquiring market-leading products and technologies, focused on bolt-on acquisitions 4 1 As of February 1, 2026. M&A Highlight: Scinomix, Inc. Acquisition funnel update1 Description: A leading manufacturer of technologies that help to streamline automation workflows driving throughput, accuracy, and traceability across various end markets within Life Sciences Annual Revenue: ~$15M Purchase Multiple: ~10x Headquarters: Earth City, Missouri Close: January 2, 2026 Segment: P&ST Rationale: Enhances our capabilities in life science applications, enabling Ingersoll Rand to combine several existing technologies with Scinomix’s offerings to provide comprehensive, end-to-end solutions in lab environments 9 Additional transactions at LOI stage 200+ Companies currently in the funnel ~90% Deals internally sourced Full year 2025 key metrics 16 Transactions closed ~$275M Annualized inorganic revenue acquired ~9x Pre-synergy Adjusted EBITDA purchase multiple 400-500bps Expected annualized inorganic revenue to be acquired in 2026 $525M Invested in inorganic growth
Page 5
5 5 Orders Revenue Adj. EBITDA & Margin1 Adj. Diluted EPS1,2 Up 8% Up 10% Up 9%, down 30 bps Up 14% Q4 2025 vs. Q4 2024 financial performance1 ($M, excl. EPS) • Organic orders up 1% YoY with positive organic growth across both segments • Book to Bill of 0.93x, consistent with typical seasonality • Organic revenue1 up 3% YoY • Aftermarket: 35% of total revenue • Adjusted EBITDA margin decreased compared to 2024 primarily due to: • The dilutive impact of tariffs • Investments for growth • Adjusted Diluted EPS up 14% YoY 1 Non-GAAP measure (definitions and/or reconciliations in appendix). 2 Adjusted Diluted EPS defined as (Adjusted Net Income) / (Diluted Average Shares Outstanding).
Page 6
6 5 Orders Revenue Adj. EBITDA & Margin1 Adj. Diluted EPS1,2 Up 9% Up 6% Up 4%, down 50 bps Up 2% FY 2025 vs. FY 2024 financial performance1 ($M, excl. EPS) • Organic orders up 1% YoY with positive organic growth across both segments • Book to Bill of 1.01x • Backlog up LDD year over year • Aftermarket: 36% of total revenue • Adjusted EBITDA margin decreased compared to 2024 primarily due to: • The dilutive impact of tariffs • Investments for growth • Adjusted Diluted EPS up 2% YoY 1 Non-GAAP measure (definitions and/or reconciliations in appendix). 2 Adjusted Diluted EPS defined as (Adjusted Net Income) / (Diluted Average Shares Outstanding).
Page 7
7 1 Non-GAAP measure (definitions and/or reconciliations in appendix). ($35) 4 • Total available liquidity of $3.8B including: • Cash and Cash Equivalents: $1.2B • Available Revolving Credit Facility Balance: $2.6B • $1.6B capital deployed in 2025: • $1,018M in share repurchases • $525M deployed to M&A • $32M through dividend payment Liquidity and Leverage Free Cash Flow1 ($M) Leverage Cash Flows from Operations less Capex (Net Debt / LTM Adjusted EBITDA) Q4 2025 financial performance ($38)
Page 8
8 • Book to Bill of 0.93x; YTD Book to Bill of 1.01x • Organic orders up 1% for both Q4 and FY ’25 • Delivered FY ’25 organic order growth across all regions as well as in Power Tools & Lifting • Adjusted EBITDA margin down year over year, primarily driven by: • Dilutive impact of tariffs • Continued commercial investments for growth Highlights Innovation in Action 4 5Current Year Prior Year YoY ∆ Ex-FX YoY ∆ Revenue $1,672.2 $1,511.0 10.7% 7.4% Adj. EBITDA $484.1 $457.6 5.8% — Adj. EBITDA Margin 28.9% 30.3% (140)bps — Organic FX M&A YoY ∆ Orders Growth 1.0% 2.9% 5.0% 8.9% Revenue Growth 2.7% 3.3% 4.7% 10.7% Q4 2025 vs. Q4 2024 Revenue/Orders BridgeQ4 2025 vs. Q4 2024 ($M) Industrial Technologies and Services Broad range of compressor, vacuum, blower, and air treatment solutions as well as industrial technologies including power too ls and lifting equipment 1 Versus traditional aeration technology using 9"disc diffusers with straight lobe blower packages. 2 Management estimate based on a 5-to-7-year membrane cycle compared to a traditional diffuser system. Satellite aeration diffuser for use in wastewater treatment applications Patent-pending ultra-low flux aeration diffuser technology paired with our existing high-efficiency blower technology and controls delivers a higher oxygen transfer at reduced energy consumption Up to 34% Energy savings1 < 18 month Payback1 Up to 8x Aftermarket replacement revenue2 Aeration Blower Controls
Page 9
9 4 5Current Year Prior Year YoY ∆ Ex-FX YoY ∆ Revenue $419.0 $387.6 8.1% 5.0% Adj. EBITDA $127.4 $106.8 19.3% — Adj. EBITDA Margin 30.4% 27.6% 280 bps — Organic FX M&A YoY ∆ Orders Growth 1.4% 3.3% 1.8% 6.5% Revenue Growth 3.7% 3.1% 1.3% 8.1% Q4 2025 vs. Q4 2024 Revenue/Orders BridgeQ4 2025 vs. Q4 2024 ($M) • Book to Bill of 0.96x; YTD Book to Bill of 1.00x • Organic orders up 1% in Q4; up 2% for FY ’25 • Q4 Life Science business organic orders up mid-teens • Organic revenue up 4% in Q4; up 1% for FY’25 • Q4 Adj. EBITDA margin up 280 bps year over year • FY Adj. EBITDA margin finished at 30%; up 40 bps year over year Highlights Innovation in Action 1 Management estimate Precision and Science Technologies Mission-critical precision liquid, gas, air, and powder handling technologies for life sciences and industrial applications as well as aerospace and defense applications EZ JetFlo wins Best of Industry Award – 2025 Innovation in Process Technology • EZ JetFlo is a single-use, disposable mixer for biopharma production, featuring a closed transfer design that enhances safety by minimizing cross-contamination risks and protecting operators from airborne powders • When used with EZ BioPac® bags, it provides rapid turnaround with no cleaning or validation required, while offering easy operation and rapid powder dissolution vs. competitive alternatives1
Page 10
10 1 See slide 2 regarding non-GAAP financial measures.2 All revenue outlook commentary expressed in percentages and based on growth as compared to 2025. 3 Non-GAAP measure (definitions and/or reconciliations in appendix). 4 Based on December 2025 FX rates; does not include the impact of FX on M&A. 5 Reflects revenue from all completed and closed M&A transactions as of February 1, 2026. 2026 full-year guidance1 Guidance Metric Full Year 2026 Full Year Assumptions Revenue Growth2 2.5% to 4.5% • Currency4: +1% • M&A5: +1.5% • Organic growth: flat to +2% • Revenue phasing: 1H 48% | 2H 52% Adjusted EBITDA3 $2,130M - $2,190M • Corporate costs: ~$170M • Adj. EBITDA phasing: 1H 46% | 2H 54% Adjusted EPS3 $3.45 to $3.57 +5% growth at the midpoint • Net interest expense: ~$230M • Adj. tax rate: ~23% • Share count: ~394M • Adj. EPS phasing: 1H 46% | 2H 54% Free Cash Flow3 to Adj. Net Income conversion ~95% • CAPEX: ~2% of sales • The phasing of Revenue, Adjusted EBITDA, and Adjusted EPS is consistent with prior years
Page 11
11 Remain nimble in what continues to be a complex global environment ▪ We will further leverage our robust global in-region, for-region manufacturing capabilities while opportunistically pivoting to favorable end markets Continuing to differentiate Ingersoll Rand as an investment: ▪ Proven track record of agility and performance ▪ Execute on the multiple levers available to deliver market outperformance Executing on strategic opportunities supported by ample liquidity and strong balance sheet Disciplined and comprehensive capital allocation strategy compounds earnings and continues to deliver durable value creation for our shareholders IRX is our backbone and continues to enable outperformance across the organization Key Takeaways Investing with Ingersoll Rand 11
Page 12
Appendix
Page 13
13 Q4 2025 financial performance – As Reported ($M, excl. EPS) Net Income1 Diluted EPS2 Up 16% Up $0.10 1 Net Income as reported defined as Net Income Attributable to Ingersoll Rand Inc. 2 Diluted EPS defined as (Net Income Attributable to Ingersoll Rand Inc.) / (Diluted Average Shares Outstanding).
Page 14
14 FY 2025 financial performance – As Reported ($M, excl. EPS) Net Income1 Diluted EPS2 Down 31% Down $(0.61) 1 Net Income as reported defined as Net Income Attributable to Ingersoll Rand Inc. 2 Diluted EPS defined as (Net Income Attributable to Ingersoll Rand Inc.) / (Diluted Average Shares Outstanding).
Page 15
15 Non-GAAP measures of financial performance In addition to consolidated GAAP financial measures, Ingersoll Rand reviews various non-GAAP financial measures, including “Organic Revenue Growth/(Decline),” “Adjusted EBITDA,” “Adjusted EBITDA Margin,” “Adjusted Net Income,” “Adjusted Net Income Attributable to Ingersoll Rand Inc.,” “Adjusted Diluted EPS,” “Free Cash Flow,” a nd “Free Cash Flow Margin.” Ingersoll Rand believes Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Net Income Attributable to Ing ersoll Rand Inc., and Adjusted Diluted EPS are helpful supplemental measures to assist management and investors in evaluating the Company’s operating results as they exclude certain items that are unusual in nature or whose fluctuation from period to period do not necessarily correspond to changes in the operations of Ingersoll Rand’s business. Ingersoll Rand believes Organic Revenue Growth/(Decline) is a helpful supplemental measure to assist management and investors in evaluating the Company’s operating results as it excludes the impact of foreign currency and acquisitions on revenue growth. Adjusted EBITDA represents net income before interest, taxes, depreciation, amortization and certain non-cash, non-recurring and other adjustment items. Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Revenue. Adjusted Net Income is defined as net income including interest, depreciation and amortization of non-acquisition related intangible assets and excluding other items used to calculate Adjusted EBITDA and further adjusted for the tax effect of these exclusions. Adjusted Net Income Attributable to Ingersoll Rand Inc. is defined as Adjusted Net Income less net income attributable to noncontrolling interest. Adjusted Diluted EPS is defined as Adjusted Net Income Attributable to Ingersoll Rand Inc. divided by Adjusted Diluted Average Shares Outstanding. Organic Revenue Growth/(Decline) is defined as As Reported Revenue growth less the impacts of Foreign Currency and Acquisitions. Ingersoll Rand believes that the adjustments applied in presenting Adjusted EBITDA, Adjusted Net Income and Adjusted Net Income Attributable to Ingersoll Rand Inc. are appropriate to provide additional information to investors about certain material non-cash items and about non-recurring items that the Company does not expect to continue at the same level in the future. Incrementals/Decrementals are defined as the change in Adjusted EBITDA versus the prior year period divided by the change in revenue versus the prior year period. Ingersoll Rand uses Free Cash Flow and Free Cash Flow Margin to review the liquidity of its operations. Ingersoll Rand measures Free Cash Flow as cash flows from operating activities less capital expenditures. Free Cash Flow Margin is defined as Free Cash Flow divided by Revenue. Ingersoll Rand believes Free Cash Flow and Free Cash Flow Margin are useful supplemental financial measures for management and investors in assessing the Company’s ability to pursue business opportunities and investments and to service its debt. Free Cash Flow is not a measure of our liquidity under GAAP and should not be considered as an alternative to cash flows from operating activities. Management and Ingersoll Rand’s board of directors regularly use these measures as tools in evaluating the Company’s operating and financial performance and in establishing discretionary annual compensation. Such measures are provided in addition to and should not be considered to be a substitute for, or superior to, the comparable measures under GAAP. In addition, Ingersoll Rand believes that Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Net Income Attributable to Ingersoll Rand Inc., Adjusted Diluted EPS, Incrementals/Decrementals, Free Cash Flow and Free Cash Flow Margin are frequently used by investors and other interested parties in the evaluation of issuers, many of which also present Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Net Income Attributable to Ingersoll Rand Inc., Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin when reporting their results in an effort to facilitate an understanding of their operating and financial results and liquidity. Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Net Income Attributa ble to Ingersoll Rand Inc., Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin should not be considered as alternatives to revenue growth, net income, diluted earnings per share or any other performance measure derived in accordance with GAAP, or as alternatives to cash flow from operating activities as a measure of our liquidity. Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Net Income Attributable to Ingersoll Rand Inc., Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin have limitations as analytical tools, and you should not consider such measures either in isolation or as substitutes for analyzing Ingersoll Rand’s results as reported under GAAP. Reconciliations of Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Net Income Attributable to Ingersoll Rand Inc., Adjusted Diluted EPS, Free Cash Flow and Free Cash Flow Margin to their most comparable U.S. GAAP financial metrics for historical periods are presented in this appendix. Reconciliations of non-GAAP measures related to full-year 2026 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results. Due to rounding, numbers presented throughout this presentation may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures.
Page 16
16 Combined Financial Information by Segment For the Three Months Ended December 31, 2025 For the Twelve Months Ended December 31, 2025 Ingersoll Rand Orders $ 1,951.7 $ 7,715.9 Revenue $ 2,091.2 $ 7,650.9 Adjusted EBITDA $ 580.1 $ 2,093.8 Adjusted EBITDA Margin 27.7% 27.4% Adjusted Net Income $ 384.1 $ 1,348.1 Adjusted Net Income Margin 18.3% 17.6% Adjusted Diluted EPS $ 0.96 $ 3.34 Free Cash Flow $ 461.5 $ 1,220.1 Free Cash Flow Margin 22.1% 15.9% Industrial Technologies & Services Orders $ 1,549.5 $ 6,119.6 Revenue $ 1,672.2 $ 6,056.4 Segment Adjusted EBITDA $ 484.1 $ 1,747.9 Segment Adjusted EBITDA Margin 28.9% 28.9% Precision & Science Technologies Orders $ 402.2 $ 1,596.3 Revenue $ 419.0 $ 1,594.5 Segment Adjusted EBITDA $ 127.4 $ 478.0 Segment Adjusted EBITDA Margin 30.4% 30.0%
Page 17
17 (Unaudited; in millions, except per share amounts) For the Three Month Period Ended December 31, For the Twelve Month Period Ended December 31, 2025 2024 2025 2024 Net Income $ 268.4 $ 231.9 $ 588.8 $ 846.3 Plus: Provision for income taxes 66.3 88.2 219.4 262.5 Amortization of acquisition related intangible assets 107.0 93.0 377.4 364.3 Impairment of goodwill and other intangible assets 7.6 13.9 273.4 13.9 Restructuring and related business transformation costs 23.0 8.0 51.7 32.3 Acquisition and other transaction related related expenses and non -cash charges 4.0 0.3 26.0 59.8 Stock-based compensation 7.2 15.2 53.0 58.8 Foreign currency transaction losses (gains), net 3.0 (6.0) 18.6 3.2 Loss on equity method investments — 5.0 127.1 24.0 Loss on extinguishment of debt — — — 3.0 Adjustments to LIFO inventories 2.3 (0.5) 17.8 6.7 Cybersecurity incident costs — — (1.3) 0.5 Loss on asbestos sale — — — 58.8 Other adjustments (1.2) (0.6) (5.9) 0.4 Minus: Income tax provision, as adjusted 103.5 104.8 397.9 385.2 Adjusted Net Income 384.1 343.6 1,348.1 1,349.3 Less: Net income attributable to noncontrolling interest 2.3 2.1 7.4 7.7 Adjusted Net Income Attributable to Ingersoll Rand Inc. $ 381.8 $ 341.5 $ 1,340.7 $ 1,341.6 Adjusted Basic Earnings Per Share1 $ 0.97 $ 0.85 $ 3.37 $ 3.33 Adjusted Diluted Earnings Per Share2 $ 0.96 $ 0.84 $ 3.34 $ 3.29 Average shares outstanding: Basic, as reported 393.0 403.0 398.1 403.4 Diluted, as reported 395.8 406.6 401.0 407.2 Adjusted diluted2 395.8 406.6 401.0 407.2 1 Adjusted basic and diluted earnings per share are calculated by dividing adjusted net income by the basic and diluted averageshares outstanding for the respective periods. 2 Adjusted diluted share count and adjusted diluted earnings per share include incremental dilutive shares, using the treasury stock method, which are added to average shares outstanding. Reconciliation of Net Income to Adjusted Net Income and Adjusted Diluted Earnings per Share
Page 18
18 (Unaudited; in millions) For the Three Month Period Ended December 31, For the Twelve Month Period Ended December 31, 2025 2024 2025 2024 Net Income $ 268.4 $ 231.9 $ 588.8 $ 846.3 Plus: Interest expense 64.9 61.8 253.9 213.2 Provision for income taxes 66.3 88.2 219.4 262.5 Depreciation expense 30.4 27.5 113.8 105.0 Amortization expense 109.7 95.2 387.5 373.0 Impairment of goodwill and other intangible assets 7.6 13.9 273.4 13.9 Restructuring and related business transformation costs 23.0 8.0 51.7 32.3 Acquisition and other transaction related expenses and non -cash charges 4.0 0.3 26.0 59.8 Stock-based compensation 7.2 15.2 53.0 58.8 Foreign currency transaction losses (gains), net 3.0 (6.0) 18.6 3.2 Loss on equity method investments — 5.0 127.1 24.0 Loss on extinguishment of debt — — — 3.0 Adjustments to LIFO inventories 2.3 (0.5) 17.8 6.7 Cybersecurity incident costs — — (1.3) 0.5 Loss on asbestos sale — — — 58.8 Interest income on cash and cash equivalents (5.5) (7.6) (30.0) (43.3) Other adjustments (1.2) (0.6) (5.9) 0.4 Adjusted EBITDA $ 580.1 $ 532.3 $ 2,093.8 $ 2,018.1 Minus: Interest expense 64.9 61.8 253.9 213.2 Income tax provision, as adjusted 103.5 104.8 397.9 385.2 Depreciation expense 30.4 27.5 113.8 105.0 Amortization of non-acquisition related intangible assets 2.7 2.2 10.1 8.7 Interest income on cash and cash equivalents (5.5) (7.6) (30.0) (43.3) Adjusted Net Income $ 384.1 $ 343.6 $ 1,348.1 $ 1,349.3 Cash Flows from Operating Activities 499.0 526.2 1,355.7 1,396.7 Minus: Capital expenditures 37.5 35.3 135.6 149.1 Free Cash Flow $ 461.5 $ 490.9 $ 1,220.1 $ 1,247.6 Reconciliation of Net Income to Adjusted EBITDA and Adjusted Net Income and Cash Flows from Operating Activities to Free Cash Flow
Page 19
19 (Unaudited; in millions) For the Three Month Period Ended December 31, For the Twelve Month Period Ended December 31, 2025 2024 2025 2024 Orders Industrial Technologies and Services $ 1,549.5 $ 1,422.2 $ 6,119.6 $ 5,706.6 Precision and Science Technologies 402.2 377.8 1,596.3 1,398.9 Total Orders $ 1,951.7 $ 1,800.0 $ 7,715.9 $ 7,105.5 Revenue Industrial Technologies and Services $ 1,672.2 $ 1,511.0 $ 6,056.4 $ 5,818.1 Precision and Science Technologies 419.0 387.6 1,594.5 1,416.9 Total Revenue $ 2,091.2 $ 1,898.6 $ 7,650.9 $ 7,235.0 Segment Adjusted EBITDA Industrial Technologies and Services $ 484.1 $ 457.6 $ 1,747.9 $ 1,754.8 Precision and Science Technologies 127.4 106.8 478.0 418.8 Total Segment Adjusted EBITDA $ 611.5 $ 564.4 $ 2,225.9 $ 2,173.6 Less items to reconcile Segment Adjusted EBITDA to Income Before Income Taxes: Corporate expenses not allocated to segments $ 31.4 $ 32.1 $ 132.1 $ 155.5 Interest expense 64.9 61.8 253.9 213.2 Depreciation and amortization expense 140.1 122.7 501.3 478.0 Impairment of goodwill and other intangible assets 7.6 13.9 273.4 13.9 Restructuring and related business transformation costs 23.0 8.0 51.7 32.3 Acquisition and other transaction related expenses and non -cash charges 4.0 0.3 26.0 59.8 Stock-based compensation 7.2 15.2 53.0 58.8 Foreign currency transaction losses (gains), net 3.0 (6.0) 18.6 3.2 Loss on extinguishment of debt — — — 3.0 Adjustments to LIFO inventories 2.3 (0.5) 17.8 6.7 Cybersecurity incident costs — — (1.3) 0.5 Loss on asbestos sale — — — 58.8 Interest income on cash and cash equivalents (5.5) (7.6) (30.0) (43.3) Other adjustments (1.2) (0.6) (5.9) 0.4 Income Before Income Taxes 334.7 325.1 935.3 1,132.8 Provision for income taxes 66.3 88.2 219.4 262.5 Loss on equity method investments — (5.0) (127.1) (24.0) Net Income $ 268.4 $ 231.9 $ 588.8 $ 846.3 Reconciliation of Segment Adjusted EBITDA to Net Income
Page 20
20 Orders and revenue growth by Segment1 (Unaudited) For the Three Month Period Ended December 31, 2025 Orders Revenue Ingersoll Rand Organic growth 1.1% 2.9% Impact of foreign currency 3.0% 3.3% Impact of acquisitions 4.4% 4.0% Total adjusted orders and revenue growth 8.5% 10.2% Industrial Technologies & Services Organic growth 1.0% 2.7% Impact of foreign currency 2.9% 3.3% Impact of acquisitions 5.0% 4.7% Total adjusted orders and revenue growth 8.9% 10.7% Precision & Science Technologies Organic growth 1.4% 3.7% Impact of foreign currency 3.3% 3.1% Impact of acquisitions 1.8% 1.3% Total adjusted orders and revenue growth 6.5% 8.1% (1) Organic growth, impact of foreign currency, and impact of acquisitions are non-GAAP adjustments. References to “impact of acquisitions” refer to GAAP sales from acquired businesses recorded prior to the first anniversary of the acquisition. The portion of GAAP revenue attributable to currency translation is calculated as the difference between (a) the period-to-period change in revenue (excluding acquisition sales) and (b) the period-to-period change in revenue (excluding acquisition sales) after applying prior year foreign exchange rates to the current year period.